micro-blood-sampling-labortory-animals

reduce animal usage in preclinical research by up to sevenfold

 

Your ethical, scientific, and financial advantage.
case-studies-preclinical-animal-research-blood-microsampling-solution

Preclinical animal research is a necessity for the development of life saving medicines. Microsampling technology offers several advantages  for PK/PD, toxicity and efficacy studies such as decreased costs and improved data quality.

vams-case-studies-micro-blood-sampling-lab-rats

This VAMS™ resource compilation includes case studies that go into detail about the ability of the technology to deliver:  

  • Seven fold reduction in animal usage in research studies 
  • A pharmacokinetic (PK) profile from a single animal
  • Consistent, robust collection of 10 µL blood samples
  • Data that bridges to the plasma gold standard
solution-to-inter-animal-varialbility-animal-blood-sampling

Compared to wet blood collection from rodents, dried blood microsampling is simpler, more economical, and more effective.

  • Significantly reduce animal usage and comply with the 3Rs
  • Generate cleaner data due to reduced animal stress
  • Improve data consistency by reducing inter-animal variability
  • Eliminate dependence on satellite populations
  • Eliminate steps, processing, and equipment without sacrificing data quality

Save Time, Save Labor, Promote The 3Rs

Easy to Use

A less stressful animal experience helps preserve the integrity of the data - and it's less stressful for staff, too.

Simplify

Microsampling eliminates the need for tubes, clips, and other equipment. When you simplify collection, you simplify your entire workflow.

Reduce / Refine

Mitra microsampling promotes the reduction of animals used in research and refines the process of collecting blood from animals. 

Drop us a line

Neoteryx, LLC

421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com
The Mitra Microsampler class I medical device is for direct specimen collection and transportation of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements. The Mitra Microsampling Device is a FDA listed Class 1 exempt device. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485. 
Copyright © 2019 Neoteryx, LLC. All rights reserved.